Abstract
Many cases of adrenal lesions, known as adrenal incidentalomas, are discovered incidentally on CT scans performed for other medical conditions. Whilst they are largely benign, these lesions can be secretory and/or malignant. Therefore, early investigation is crucial to promptly and efficiently manage those requiring intervention whilst to reassuring the remaining majority in a timely manner. Traditionally, the detection of adrenal lesions on CT scans relies on manual analysis by radiologists, which can be time-consuming and unsystematic. Using AI and deep learning, we examined whether or not applying these technology can augment the detection of adrenal incidentalomas in CT scans. We developed a 2.5D deep learning model to perform image classification on 3D CT scans of patients to classify between lesion and healthy adrenal glands. When tested on an independent test set, our 2.5D model obtained an AUC of the ROC curve of 0.95, and a classification sensitivity of 0.86, and specificity of 0.89. These results suggest that deep learning may be a promising tool for detecting adrenal lesions and improving patient care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was conducted by the NHS AI Lab Skunkworks, an NHS England programme, in partnership with University Hospitals of North Midlands NHS Trust. The project was funded by the NHS AI Lab Skunkworks and made use of imaging data provided by the University Hospitals of North Midlands NHS Trust for the sole use of this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This proof of concept development project is not classified as research and therefore did not require ethical approvals. A stringent information governance process was followed, including fully anonymising patient data prior to sharing, and agreed by NHS England and the University Hospitals North Midlands NHS Trust information governance teams.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† sansonpoon.nhs{at}gmail.com
↵‡ fahmy.hanna{at}uhnm.nhs.uk
↵2 https://github.com/nhsx/skunkworks-adrenal-lesions-detection
Data Availability
Algorithm code base is published on GitHub. Data and the models weights for transfer learning underlying this article will be shared on reasonable request to the corresponding author.
https://github.com/nhsx/skunkworks-adrenal-lesions-detection
